Cargando…

DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer, and the third leading cause of cancer death worldwide. Studies have shown that increased angiopoietin-2 (Ang-2) expression relative to Ang-1 expression in tumors is associated with a poor prognosis.The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jing, Du, Pei-Zhuo, Yang, Cui, Tao, Yun-Yun, Li, Li, Li, Zu-Mao, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556176/
https://www.ncbi.nlm.nih.gov/pubmed/37495746
http://dx.doi.org/10.1007/s00261-023-04007-8
_version_ 1785116823721607168
author Zheng, Jing
Du, Pei-Zhuo
Yang, Cui
Tao, Yun-Yun
Li, Li
Li, Zu-Mao
Yang, Lin
author_facet Zheng, Jing
Du, Pei-Zhuo
Yang, Cui
Tao, Yun-Yun
Li, Li
Li, Zu-Mao
Yang, Lin
author_sort Zheng, Jing
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer, and the third leading cause of cancer death worldwide. Studies have shown that increased angiopoietin-2 (Ang-2) expression relative to Ang-1 expression in tumors is associated with a poor prognosis.The purpose of this study was to investigate the efficacy of predicting Ang-2 expression in HCC by preoperative dynamic contrast‐enhanced magnetic resonance imaging (DCE-MRI)-based radiomics. METHODS: The data of 52 patients with HCC who underwent surgical resection in our hospital were retrospectively analyzed. Ang-2 expression in HCC was analyzed by immunohistochemistry. All patients underwent preoperative upper abdominal DCE-MRI and intravoxel incoherent motion diffusion-weighted imaging scans. Radiomics features were extracted from the early and late arterial and portal phases of axial DCE-MRI. Univariate analysis and least absolute shrinkage and selection operator (LASSO) was performed to select the optimal radiomics features for analysis. A logistic regression analysis was performed to establish a DCE-MRI radiomics model, clinic-radiologic (CR) model and combined model integrating the radiomics score with CR factors. The stability of each model was verified by 10-fold cross-validation. Receiver operating characteristic (ROC) curve analysis, calibration curve analysis and decision curve analysis (DCA) were employed to evaluate these models. RESULTS: Among the 52 HCC patients, high Ang-2 expression was found in 30, and low Ang-2 expression was found in 22. The areas under the ROC curve (AUCs) for the radiomics model, CR model and combined model for predicting Ang-2 expression were 0.800, 0.874, and 0.933, respectively. The DeLong test showed that there was no significant difference in the AUC between the radiomics model and the CR model (p > 0.05) but that the AUC for the combined model was significantly greater than those for the other 2 models (p < 0.05). The DCA results showed that the combined model outperformed the other 2 models and had the highest net benefit. CONCLUSION: The DCE-MRI-based radiomics model has the potential to predict Ang-2 expression in HCC patients; the combined model integrating the radiomics score with CR factors can further improve the prediction performance. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10556176
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-105561762023-10-07 DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma Zheng, Jing Du, Pei-Zhuo Yang, Cui Tao, Yun-Yun Li, Li Li, Zu-Mao Yang, Lin Abdom Radiol (NY) Hepatobiliary BACKGROUND: Hepatocellular carcinoma (HCC) is the sixth most common cancer, and the third leading cause of cancer death worldwide. Studies have shown that increased angiopoietin-2 (Ang-2) expression relative to Ang-1 expression in tumors is associated with a poor prognosis.The purpose of this study was to investigate the efficacy of predicting Ang-2 expression in HCC by preoperative dynamic contrast‐enhanced magnetic resonance imaging (DCE-MRI)-based radiomics. METHODS: The data of 52 patients with HCC who underwent surgical resection in our hospital were retrospectively analyzed. Ang-2 expression in HCC was analyzed by immunohistochemistry. All patients underwent preoperative upper abdominal DCE-MRI and intravoxel incoherent motion diffusion-weighted imaging scans. Radiomics features were extracted from the early and late arterial and portal phases of axial DCE-MRI. Univariate analysis and least absolute shrinkage and selection operator (LASSO) was performed to select the optimal radiomics features for analysis. A logistic regression analysis was performed to establish a DCE-MRI radiomics model, clinic-radiologic (CR) model and combined model integrating the radiomics score with CR factors. The stability of each model was verified by 10-fold cross-validation. Receiver operating characteristic (ROC) curve analysis, calibration curve analysis and decision curve analysis (DCA) were employed to evaluate these models. RESULTS: Among the 52 HCC patients, high Ang-2 expression was found in 30, and low Ang-2 expression was found in 22. The areas under the ROC curve (AUCs) for the radiomics model, CR model and combined model for predicting Ang-2 expression were 0.800, 0.874, and 0.933, respectively. The DeLong test showed that there was no significant difference in the AUC between the radiomics model and the CR model (p > 0.05) but that the AUC for the combined model was significantly greater than those for the other 2 models (p < 0.05). The DCA results showed that the combined model outperformed the other 2 models and had the highest net benefit. CONCLUSION: The DCE-MRI-based radiomics model has the potential to predict Ang-2 expression in HCC patients; the combined model integrating the radiomics score with CR factors can further improve the prediction performance. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-07-26 2023 /pmc/articles/PMC10556176/ /pubmed/37495746 http://dx.doi.org/10.1007/s00261-023-04007-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Hepatobiliary
Zheng, Jing
Du, Pei-Zhuo
Yang, Cui
Tao, Yun-Yun
Li, Li
Li, Zu-Mao
Yang, Lin
DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title_full DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title_fullStr DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title_full_unstemmed DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title_short DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
title_sort dce-mri-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
topic Hepatobiliary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556176/
https://www.ncbi.nlm.nih.gov/pubmed/37495746
http://dx.doi.org/10.1007/s00261-023-04007-8
work_keys_str_mv AT zhengjing dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT dupeizhuo dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT yangcui dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT taoyunyun dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT lili dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT lizumao dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma
AT yanglin dcemribasedradiomicsinpredictingangiopoietin2expressioninhepatocellularcarcinoma